Cinctive Capital Management LP Grows Holdings in Avantor, Inc. (NYSE:AVTR)

Cinctive Capital Management LP increased its holdings in Avantor, Inc. (NYSE:AVTR) by 53.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 159,242 shares of the company’s stock after acquiring an additional 55,756 shares during the quarter. Cinctive Capital Management LP’s holdings in Avantor were worth $4,120,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Tidal Investments LLC lifted its holdings in shares of Avantor by 19.6% during the first quarter. Tidal Investments LLC now owns 14,654 shares of the company’s stock valued at $375,000 after purchasing an additional 2,399 shares during the last quarter. Cetera Advisors LLC purchased a new position in Avantor during the first quarter valued at $249,000. DNB Asset Management AS boosted its holdings in Avantor by 7.6% in the second quarter. DNB Asset Management AS now owns 118,739 shares of the company’s stock worth $2,517,000 after acquiring an additional 8,436 shares in the last quarter. Versant Capital Management Inc grew its stake in shares of Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after acquiring an additional 1,102 shares during the last quarter. Finally, Park Avenue Securities LLC grew its stake in shares of Avantor by 5.9% in the second quarter. Park Avenue Securities LLC now owns 45,297 shares of the company’s stock worth $960,000 after acquiring an additional 2,522 shares during the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages recently issued reports on AVTR. Barclays dropped their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. UBS Group dropped their target price on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research note on Tuesday, October 8th. Royal Bank of Canada reissued an “outperform” rating and set a $34.00 price target on shares of Avantor in a research report on Thursday, September 26th. Robert W. Baird lowered their price objective on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. Finally, Wells Fargo & Company cut their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Avantor has an average rating of “Moderate Buy” and a consensus price target of $27.57.

Insider Activity

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.50% of the company’s stock.

Avantor Stock Up 0.1 %

AVTR stock opened at $21.09 on Tuesday. The company has a market cap of $14.35 billion, a price-to-earnings ratio of 45.85, a P/E/G ratio of 2.55 and a beta of 1.35. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. The business’s 50-day moving average is $23.28 and its two-hundred day moving average is $23.71. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.